SCHEMBL6924233

SCHEMBL6924233

CC(=O)Nc1cccc(-c2c[nH]cn2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.56
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
TP53 P04637 1/20 0.56
STAT1 P42224 1/20 0.56
FYN P06241 3/20 0.53
JAK3 P52333 1/20 0.53
MELK Q14680 1/20 0.53
MAPT P10636 3/20 0.53
ALDH1A1 P00352 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HSD17B10 Q99714 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
KDM1A O60341 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
NTRK1 P04629 1/20 0.50
PIK3C3 Q8NEB9 1/20 0.50
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10953295 0.83 KDM4E (0.55) SMN1; SMN2NPC1RAB9ATP53MAPT
SCHEMBL7728110 0.82 KMT2A (0.60) SMN1; SMN2NPC1RAB9ATP53MAPT
SCHEMBL12647571 0.82 MAP4K4 (0.49) FYNNTRK1
SCHEMBL12852522 0.80 NTRK1 (0.45) SMN1; SMN2NPC1RAB9ATP53STAT1
SCHEMBL7138395 0.78 NQO2 (0.58) SMN1; SMN2NPC1RAB9ATP53STAT1
SCHEMBL5612710 0.77 MAPT (0.59) SMN1; SMN2NPC1RAB9ATP53STAT1
SCHEMBL2648173 0.77 CNR1 (0.65) SMN1; SMN2NPC1RAB9ATP53STAT1
SCHEMBL22284859 0.76 CYP17A1 (0.64) FYNMAPTCYP17A1
SCHEMBL10953287 0.76 IKBKB (0.45)
SCHEMBL5690790 0.76 CYP17A1 (0.64) MAPTNQO2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004101533-A1 1, 3, 4-BENZOTRIAZEPIN-2-ONE SALTS AND THEIR USE AS CCK RECEPTOR LIGANDS JANSSEN PHARMACEUTICA, N.V. (US) 2004-11-25 WO disclosed